<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266706/" ref="ordinalpos=2256&amp;ncbi_uid=6970591&amp;link_uid=PMC4266706" image-link="/pmc/articles/PMC4266706/figure/fig04/" class="imagepopup">Figure 4.  From: DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt <span class="highlight" style="background-color:">signaling</span>. </a></div><br /><div class="p4l_captionBody">DACT2 inhibits both Wnt/β-catenin and Wnt/c-Jun signaling pathway. A. Results of TCF/LEF luciferase reporter assay. TopFlash: TCF/LEF-responsive reporter; pRL-TK: internal control; WT: wild-type; Mut: mutant. B. p-β-catenin, β-catenin, C-myc and p-c-Jun expression. p-β-catenin: phosphorylated β-catenin; p-c-Jun: phosphorylated c-Jun. Con siRNA: siRNA control; 8# siRNA: DACT2 siRNA #8.</div></div>